SCHEMBL23329505

SCHEMBL23329505

COC(=O)c1cc(C)cc2c1NCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.41
▸ CYP46A1 Q9Y6A2 1/20 0.39
▸ PARP10 Q53GL7 2/20 0.37
▸ PARP11 Q9NR21 1/20 0.37
▸ NR4A2 P43354 2/20 0.37
▸ POLB P06746 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ SERPINH1 P50454 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ PARP1 P09874 2/20 0.34
▸ RECQL P46063 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ XDH P47989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17802200 0.83 MAPT (0.36) MAPTPOLBSERPINH1ACHEPARP1
SCHEMBL551872 0.83 NR4A2 (0.38) MAPTPARP10PARP11NR4A2POLB
SCHEMBL14048993 0.79 NR4A2 (0.44) MAPTPARP10PARP11NR4A2POLB
SCHEMBL10661545 0.76 KDM4E (0.45) POLBPARP1KDM4EATM
SCHEMBL31562070 0.76 KDM4E (0.45) POLBPARP1KDM4EATM
SCHEMBL9177566 0.76 PARP1 (0.39) MAPTPOLBGAASERPINH1PARP1
SCHEMBL7493334 0.75 POLB (0.40) PARP10PARP11POLBGAA
SCHEMBL9181279 0.75 GAA (0.39) MAPTPOLBGAAPARP1KDM4E
SCHEMBL17433704 0.74 PARP10 (0.43) PARP10PARP11GAAPARP1KDM4E
SCHEMBL9177916 0.74 MAPT (0.38) MAPTGAASERPINH1PARP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 — — WO disclosed
Send feedback